Registry for patients undergoing pacemaker/ICD implantation including a transtricuspid lead with and without intraprocedural transesophageal echocardiography to evaluate risk factors for lead induced tricuspid regurgitation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Increase of tricuspid regurgitation by at least one grade (on a scale from 0-4)
Timeframe: 2 - 7 days post-implant (at hospital discharge)